US

S. 27 S. 27: Preserve Access to Affordable Generics Act

Summary Read full text

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. Read more

Sentiment Map

National Constituent Input

80%

20%

5 total users

State Input

0%

0%

No input from this state

District Input

0%

0%

No input from this district

Activity Feed

Filter

  • {{ cardCount('all') }} All Activity
  • {{ cardCount('Bill') }} Bill Activity
  • {{ cardCount('Congress') }} Lawmaker Activity
  • {{ cardCount('Org') }} Stakeholder Activity
  • {{ cardCount('User') }} Constituent Activity

Stakeholder Positions (4)

Endorsing

  • Academy of Managed Care Pharmacy (AMCP)
  • National Retiree Legislative Network (NRLN)

Opposing

  • Intellectual Property Owners Association